*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ribociclib intermediates are key synthetic building blocks for the CDK4/6 inhibitor used in oncology. The primary process involves multi-step organic synthesis to achieve high purity. <strong>Molecular Formula</strong>: C29H35N7O2S; <strong>CAS No</strong>: 1228535-10-5.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for breast cancer therapies.</li>
<li>Research and development of novel kinase inhibitors.</li>
<li>Quality control standards for finished drug products.</li>
</ul>
<h3>Precautions</h3>
<p>Store in a cool, dry place away from light. Handle with appropriate PPE due to potential irritancy. Strictly comply with GMP guidelines during clinical supply chain management.</p>